Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.
about
Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisInhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole ResistanceXenobiotic efflux in bacteria and fungi: a genomics updateSurface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance.The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.Microbial efflux pump inhibition: tactics and strategies.Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor.Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibilityHeterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis.Antifungal activity of redox-active benzaldehydes that target cellular antioxidation.Detection of inhibitors of Candida albicans Cdr transporters using a diS-C3(3) fluorescence.Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae.Exploring the molecular basis of antifungal synergies using genome-wide approaches.Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiaeAugmenting the Activity of Monoterpenoid Phenols against Fungal Pathogens Using 2-Hydroxy-4-methoxybenzaldehyde that Target Cell Wall Integrity.Milbemycins: more than efflux inhibitors for fungal pathogensABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.Efflux-mediated antifungal drug resistance.The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosisCurcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.A complex game of hide and seek: the search for new antifungalsUse of benzo analogs to enhance antimycotic activity of kresoxim methyl for control of aflatoxigenic fungal pathogens.Antifungal adjuvants: Preserving and extending the antifungal arsenalRole of Ectopic Gene Conversion in the Evolution of a Candida krusei Pleiotropic Drug Resistance Transporter Family.Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.Targeting efflux pumps to overcome antifungal drug resistance.Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.Identification and functional characterization of Penicillium marneffei pleiotropic drug resistance transporters ABC1 and ABC2.Augmenting the antifungal activity of an oxidizing agent with kojic Acid: control of penicillium strains infecting crops.The Candida albicans Inhibitory Activity of the Extract from Papaya (Carica papaya L.) Seed Relates to Mitochondria DysfunctionHibicuslide C-induced cell death in Candida albicans involves apoptosis mechanism.New high-throughput screening assay to reveal similarities and differences in inhibitory sensitivities of multidrug ATP-binding cassette transporters.Enhancement of commercial antifungal agents by Kojic Acid.
P2860
Q27324352-BBCC3745-0FCB-49A1-8C40-E84D95D68921Q28534020-78FD9B93-FC81-42B7-B1F5-E3A2EEF70FB7Q28547078-CE359B3F-E9A1-4DCF-8695-1E6461148B8BQ28834633-38BC7319-2986-480C-A74C-63562DD8B564Q31136813-BBF1B237-D6DC-4B7A-9545-9D8ACEEA664FQ34112865-E11690EC-D73A-4479-9DE7-4B796FD10591Q34176211-AB200E6F-FABF-4688-8ADA-8C50732E57EEQ34293596-1A125E6D-6CD3-4FB3-9594-E00E6A035D14Q34334444-8BC9869B-B292-472A-8787-9AE48823397EQ34510707-2C5BB96E-4E70-4434-A2D2-A6111000D87BQ34561878-715A66C5-3DA5-4313-A686-D1FBE499ECC5Q34733848-3831E0DE-03DB-4880-A1EA-C215BA404EB8Q35081105-2F06C8E5-F682-4EE8-A638-ADA7221B7BFAQ35158235-5F749636-EB93-4657-B567-1003B294B5D8Q35213291-0A901DD0-E664-4ACF-830F-8BE0502CEDDEQ35854979-EA733245-C0B9-4D94-AC29-5C8924630A65Q35947069-BDE7238F-62D6-45C4-9241-334547D3D766Q36324591-EECFCBBD-D8A7-4895-A221-180AD2A5D434Q36558410-BDEF1FAC-DDE6-47AD-9C91-21279FE89846Q36949532-8FF1A409-397C-4359-B7F7-D5D81C6991ADQ37072109-2DE19ED9-8A2D-4C50-8771-6139C3E4A41EQ37156645-DE010DBF-5CB4-4AA6-BB96-D003D203103BQ37264097-E13E3228-6019-4B9B-8DB8-C825F46B1424Q37274696-2434C8C6-B75B-4426-9C31-9E064C39E6BCQ37337658-5B1A0C4A-1463-419B-A717-CF8244DC2467Q37344546-3F1B22A7-DE06-4E4B-B26D-C50BC69DA4ADQ37623108-8699E8F5-66FC-458D-9D64-E79DF0B8878DQ37705308-A2A7FBF1-6D8F-465D-9FE3-A5EC138C34B5Q37735455-B7E0701F-9C84-460F-B105-9B2CE65BC871Q38684284-561EC84D-0760-4BAC-AB3F-B8681C19194DQ38835045-8654C7BB-E282-448B-93E4-C8E7A30D9459Q38837348-73ACC615-9E30-48CE-9A75-7FBF0427FAFEQ38999537-18C7D85E-8815-4292-B421-E82FB1B11CECQ39207667-B3ADB667-B936-4A7D-9224-49916A45C1CBQ39335647-B70BCF64-EADA-4581-A5D3-5131C6AA4A1EQ41661132-E6E43F97-0EC6-48FE-A61B-103FB5B6CE3FQ41661223-D9CCB5E6-1C39-4114-9745-B4DBB6860B7DQ41759566-4709E701-B181-472B-AAF4-1D350B350272Q42111717-4E1711DA-2987-4E9D-9EA7-D90CFCF0EF8DQ42365967-A17DA909-F8A9-4D24-95C8-561EA98004FD
P2860
Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Chemosensitization of fluconaz ...... by a D-octapeptide derivative.
@ast
Chemosensitization of fluconaz ...... by a D-octapeptide derivative.
@en
type
label
Chemosensitization of fluconaz ...... by a D-octapeptide derivative.
@ast
Chemosensitization of fluconaz ...... by a D-octapeptide derivative.
@en
prefLabel
Chemosensitization of fluconaz ...... by a D-octapeptide derivative.
@ast
Chemosensitization of fluconaz ...... by a D-octapeptide derivative.
@en
P2093
P2860
P1476
Chemosensitization of fluconaz ...... by a D-octapeptide derivative.
@en
P2093
A Decottignies
D R K Harding
R D Cannon
P2860
P304
P356
10.1128/AAC.48.4.1256-1271.2004
P407
P577
2004-04-01T00:00:00Z